A Canadian drug development and venture investment company with core focus on therapeutic technologies is seeking novel Canadian therapeutics in the fields of oncology and neurology. At minimum, a tool molecule showing therapeutic promise via modulation of an identified target is required as a developmental starting point. Therapeutics for other clinical indications will also be considered, provided the below criteria are met.
Approaches of Interest:
- Novel therapeutics available for partnering from Canadian biotech or academic organisations
- Diseases of...